emtricitabine - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
TENOFOVIR / EMTRICITABINE SANDOZ 301/200 tenofovir disoproxil succinate / emtricitabine 301 mg/200 mg film-coated tablet bottle AUST R: 326237Active ingredients:
emtricitabine
tenofovir disoproxil succinate
Dosage form:
Tablet, film coated
Sponsor:
Sandoz Pty Ltd
Phone:
1800726369
|
From
24 Oct 2025
to
15 May 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Alternative generic products are available.
|
TENOFOVIR DISOPROXIL/EMTRICITABINE/EFAVIRENZ Viatris 300/200/600 tenofovir disoproxil maleate 300mg/emtricitabine 200mg/efavirenz 600mg tablet bottle AUST R: 280721Active ingredients:
efavirenz
emtricitabine
tenofovir disoproxil maleate
Dosage form:
Tablet, film coated
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
From
20 Mar 2025
to
30 Apr 2026
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options.
|